H.R. 3203 · 117th Congress · House

To enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program, and for other purposes.

Active· Referred to the Subcommittee on Health.
Introduced
May 13, 21
Passed House
Pending
Passed Senate
Pending
Sent to President
Pending
Signed into Law
Pending

Executive Summary

This bill waives certain eligibility requirements for hospitals participating in the 340B drug discount program (i.e., a program that allows entities to receive covered outpatient drugs at reduced prices from manufacturers) during the COVID-19 (i.e., coronavirus disease 2019) public health emergency. Specifically, the bill waives the required minimum proportion of low-income patients served for hospitals that began participating in the program during or prior to the COVID-19 emergency.

Action Timeline

4
  1. MAY 14, 2021Committee

    Referred to the Subcommittee on Health.

  2. MAY 13, 2021IntroReferral

    Introduced in House

  3. MAY 13, 2021IntroReferral

    Introduced in House

  4. MAY 13, 2021IntroReferral

    Referred to the House Committee on Energy and Commerce.

Committees

2

Health Subcommittee

hsif14

Referred: May 14, 2021

Active

Energy and Commerce Committee

hsif00

Referred: May 13, 2021

Active